The Atlantic

Sep 28, 2026 UTC· 1 event in window

The Atlantic's coverage this period shifted from the Musk documentary ad controversy to Israeli politics. Alongside The New York Times and Haaretz, the publication reported that Netanyahu received warnings from the UAE and Egypt before the Oct. 7 Hamas attack but did not share them with security officials. Netanyahu's office denied the claims, calling them "fake news" ahead of elections.

Sep 27, 2026 UTC· 1 event in window

During this period, The Atlantic commented on an advertising controversy surrounding a documentary about Elon Musk. The publication suggested that the back-and-forth by Meta and YouTube, which initially rejected and then reinstated ads for the film, may ultimately benefit Musk.

Aug 6, 2026 UTC· 1 event in window

On August 4, reports emerged that the U.S. has nearly exhausted its stockpiles of long-range precision missiles, including ATACMS, PrSM, and over half of its Tomahawk cruise missiles, during a five-month war with Iran. The depletion, driven by a policy of avoiding piloted aircraft strikes, has strained defensive systems like Patriot and THAAD. Analysts warned that supplies may be insufficient for a prolonged conflict, potentially undermining U.S. deterrence against Russia and China.

Aug 4, 2026 UTC· 1 event in window

On August 3, an FDA advisory panel narrowly voted 8-6 to recommend easing restrictions on seven unproven synthetic peptides for compounding pharmacy use. The panel was convened by Health Secretary Robert F. Kennedy Jr., and several members were reported to have ties to the peptide industry. FDA scientists had previously cited insufficient safety and efficacy data, and critics warned the move could expand a gray market.